TIDMASEI
Aberdeen Standard Equity Income Tst
20 May 2021
Aberdeen Standard Equity Income (ASEI)
20/05/2021
Results analysis from Kepler Trust Intelligence
This week, Aberdeen Standard Equity Income (ASEI) released its
interim results for the financial year (FY) 2021. Over the six
months ending 31/03/2021, ASEI generated NAV total returns (with
income reinvested) of 29.0%. Over the same period, ASEI's share
price rose 34.8% (with income reinvested); share price returns were
boosted by a narrowing discount to c. 8.8% from c. 12.5% in
September 2020. ASEI outperformed the benchmark on both an NAV and
share price total return basis, with the FTSE All-Share Index
generating a total return of c. 18.5%.
Kepler View
Aberdeen Standard Equity Income (ASEI) has enjoyed a purple
patch, with a return to favour of cyclical stocks and value
strategies playing to its favour in recent months. After the
announcement of the successful development of vaccines for
COVID-19, there was a substantial 'catch-up' rally in many areas of
the market which had previously lagged the presumed
'covid-beneficiaries'.
When, in November 2020, we last updated our research on ASEI, we
noted that manager Thomas Moore had highlighted such a scenario as
a potential tailwind. In the face of widening valuation dispersions
between 'value' and 'growth' stocks within the market, we reported
that: "Thomas sees it as providing the scope for a very sharp
recovery in performance should conditions change. An economic
recovery, potentially (in the team's view) linked to the
announcement of a vaccine, could prove a tailwind to a recovery in
many of ASEI's holdings." This has subsequently materialised, with
ASEI outperforming the benchmark substantially over the interim
reporting period.
The board has indicated it intends to raise dividends for FY
2021 by 0.1% over FY 2020, through the payment of a third interim
dividend of 5.2p per share and a fourth interim dividend of at
least 5.1p per share (giving a total dividend of at least 20.7p per
share for the whole financial year). This would represent a yield
of c. 5.5% on the current share price. However, it has noted that
the final dividend level will remain somewhat dependent on the
degree of recovery in the revenue account.
With FY 2020 revenue returns per share of 15.61p per share, a
covered dividend at this level will require significant further
acceleration in revenue receipts. However, the board retains
recourse to significant revenue reserves, totalling c. GBP7.6m as
at 31/03/2021. This is prior to the payment of the 2(nd) interim
dividend. Kepler estimates that, after deduction of the 2(nd)
interim dividend, but accounting for reported retained earnings
(based on reported differences in ex-income and cum-income NAVs as
at 17/05/2021), ASEI retains revenue reserve cover of c. 0.77x the
FY 2020 dividend.
CLICK HERE TO READ THE FULL REPORT
Visit http://www.trustintelligence.co.uk/investor for more high
quality independent investment trust research.
Important information
This report has been issued by Kepler Partners LLP. The analyst
who has prepared this report is aware that Kepler Partners LLP has
a relationship with the company covered in this report and/or a
conflict of interest which may impair the objectivity of the
research.
Past performance is not a reliable indicator of future results.
The value of investments can fall as well as rise and you may get
back less than you invested when you decide to sell your
investments. It is strongly recommended that if you are a private
investor independent financial advice should be taken before making
any investment or financial decision.
Kepler Partners is not authorised to make recommendations to
retail clients. This report has been issued by Kepler Partners LLP,
is based on factual information only, is solely for information
purposes only and any views contained in it must not be construed
as investment or tax advice or a recommendation to buy, sell or
take any action in relation to any investment.
The information provided on this website is not intended for
distribution to, or use by, any person or entity in any
jurisdiction or country where such distribution or use would be
contrary to law or regulation or which would subject Kepler
Partners LLP to any registration requirement within such
jurisdiction or country. In particular, this website is exclusively
for non-US Persons. Persons who access this information are
required to inform themselves and to comply with any such
restrictions.
The information contained in this website is not intended to
constitute, and should not be construed as, investment advice. No
representation or warranty, express or implied, is given by any
person as to the accuracy or completeness of the information and no
responsibility or liability is accepted for the accuracy or
sufficiency of any of the information, for any errors, omissions or
misstatements, negligent or otherwise. Any views and opinions,
whilst given in good faith, are subject to change without
notice.
This is not an official confirmation of terms and is not a
recommendation, offer or solicitation to buy or sell or take any
action in relation to any investment mentioned herein. Any prices
or quotations contained herein are indicative only.
Kepler Partners LLP (including its partners, employees and
representatives) or a connected person may have positions in or
options on the securities detailed in this report, and may buy,
sell or offer to purchase or sell such securities from time to
time, but will at all times be subject to restrictions imposed by
the firm's internal rules. A copy of the firm's Conflict of
Interest policy is available on request.
PLEASE SEE ALSO OUR TERMS AND CONDITIONS
Kepler Partners LLP is authorised and regulated by the Financial
Conduct Authority (FRN 480590), registered in England and Wales at
9/10 Savile Row, London W1S 3PF with registered number
OC334771.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAZZGZKFGZGMZM
(END) Dow Jones Newswires
May 20, 2021 09:25 ET (13:25 GMT)
Standard Life Equity Income (LSE:SLET)
Historical Stock Chart
From Oct 2024 to Nov 2024
Standard Life Equity Income (LSE:SLET)
Historical Stock Chart
From Nov 2023 to Nov 2024
